The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
Scope of the Report:
This report focuses on the Microbiome Therapeutics in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen
Market Segment by Countries, covering
United States
United Kingdom
Canada
Germany
France
Italy
Spain
Market Segment by Type, covers
Market Segment by Applications, can be divided into
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
There are 19 Chapters to deeply display the North America and Europe Microbiome Therapeutics market.
Chapter 1, to describe Microbiome Therapeutics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Microbiome Therapeutics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Microbiome Therapeutics, for each country, from 2013 to 2018;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;
Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;
Chapter 14, Microbiome Therapeutics market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers, etc.
Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.
Frequently Asked Questions
These dominant industry players use well planned strategies to occupied highest market share in this market. Some of the top players in [Keyword] business includes.
[Company list]
As per [Keyword] market analysis, North America is forecasted to occupied major share in the [Keyword] market.
The statistical data of the dominant industry player of [Keyword] market can be acquired from the company profile segment described in the report. This segment come up with analysis of major player’s in the [Keyword] market, also their last five-year revenue, segmental, product offerings, key strategies adopted and geographical revenue produced.
The report come up with a segment of the [Keyword] market based on Type, Region, and Application, Also offer a determined view on the [Keyword] market.
The report offers a nitty-gritty estimation of the market by providing data on various viewpoints that incorporate, restraints, drivers, and opportunities threats. This data can help in making suitable decisions for stakeholders before investing.
The sample report for [Keyword] market can be received after the apply from the website.
Table Of Content
Table of Contents
1 Market Overview
1.1 Microbiome Therapeutics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 C. difficile Infection (CDI)
1.3.2 Inflammatory Bowel Disease (IBD)
1.3.3 Orphan Drug
1.3.4 Immuno-oncology
1.3.5 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Seres Therapeutics
2.1.1 Business Overview
2.1.2 Microbiome Therapeutics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Assembly Biosciences
2.2.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Synthetic Biologics
2.3.1 Business Overview
2.3.2 Microbiome Therapeutics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Interxon
2.4.1 Business Overview
2.4.2 Microbiome Therapeutics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 PureTech
2.5.1 Business Overview
2.5.2 Microbiome Therapeutics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Synlogic
2.6.1 Business Overview
2.6.2 Microbiome Therapeutics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Enterome BioScience
2.7.1 Business Overview
2.7.2 Microbiome Therapeutics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 4D Pharma
2.8.1 Business Overview
2.8.2 Microbiome Therapeutics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Second Genome
2.9.1 Business Overview
2.9.2 Microbiome Therapeutics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AOBiome
2.10.1 Business Overview
2.10.2 Microbiome Therapeutics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 C3 Jian
2.11.1 Business Overview
2.11.2 Microbiome Therapeutics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Rebiotix
2.12.1 Business Overview
2.12.2 Microbiome Therapeutics Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MicroBiome Therapeutics LLC
2.13.1 Business Overview
2.13.2 Microbiome Therapeutics Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Metabiomics
2.14.1 Business Overview
2.14.2 Microbiome Therapeutics Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ritter Pharmaceuticals
2.15.1 Business Overview
2.15.2 Microbiome Therapeutics Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Symberix
2.16.1 Business Overview
2.16.2 Microbiome Therapeutics Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 OpenBiome
2.17.1 Business Overview
2.17.2 Microbiome Therapeutics Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Azitra
2.18.1 Business Overview
2.18.2 Microbiome Therapeutics Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Symbiotix Biotherapies
2.19.1 Business Overview
2.19.2 Microbiome Therapeutics Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Osel
2.20.1 Business Overview
2.20.2 Microbiome Therapeutics Type and Applications
2.20.2.1 Type 1
2.20.2.2 Type 2
2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Metabogen
2.21.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.21.2.1 Type 1
2.21.2.2 Type 2
2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America and Europe Microbiome Therapeutics Market Competition, by Manufacturer
3.1 North America and Europe Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Microbiome Therapeutics Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Microbiome Therapeutics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Microbiome Therapeutics Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Microbiome Therapeutics Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America and Europe Microbiome Therapeutics Market Analysis by Countries/Regions
4.1 North America and Europe Microbiome Therapeutics Sales Market Share by Countries/Regions
4.2 North America and Europe Microbiome Therapeutics Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Microbiome Therapeutics Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Microbiome Therapeutics Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
5 North America and Europe Market Segmentation Microbiome Therapeutics by Type
5.1 North America and Europe Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
6 North America and Europe Market Segmentation Microbiome Therapeutics by Application
6.1 North America and Europe Microbiome Therapeutics Sales Market Share by Application (2013-2018)
6.2 C. difficile Infection (CDI) Sales Growth (2013-2018)
6.3 Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
6.4 Orphan Drug Sales Growth (2013-2018)
6.5 Immuno-oncology Sales Growth (2013-2018)
6.6 Others Sales Growth (2013-2018)
7 United States Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
7.2.1 United States Microbiome Therapeutics Sales by Type (2013-2018)
7.2.2 United States Microbiome Therapeutics Sales Market Share by Type (2013-2018)
7.3 United States Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
7.3.1 United States Microbiome Therapeutics Sales by Application (2013-2018)
7.3.2 United States Microbiome Therapeutics Sales Market Share by Application (2013-2018)
7.4 United States Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Microbiome Therapeutics Export and Import (2013-2018)
8 United Kingdom Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
8.1 United Kingdom Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Microbiome Therapeutics Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Microbiome Therapeutics Sales by Type (2013-2018)
8.2.2 United Kingdom Microbiome Therapeutics Sales Market Share by Type (2013-2018)
8.3 United Kingdom Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Microbiome Therapeutics Sales by Application (2013-2018)
8.3.2 United Kingdom Microbiome Therapeutics Sales Market Share by Application (2013-2018)
8.4 United Kingdom Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Microbiome Therapeutics Export and Import (2013-2018)
9 Canada Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
9.1 Canada Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
9.2.1 Canada Microbiome Therapeutics Sales by Type (2013-2018)
9.2.2 Canada Microbiome Therapeutics Sales Market Share by Type (2013-2018)
9.3 Canada "&Sheet1!$B$1&" Sales and Market Share by Application (2013-2018)"
9.3.1 Canada Microbiome Therapeutics Sales by Application (2013-2018)
9.3.2 Canada Microbiome Therapeutics Sales Market Share by Application (2013-2018)
9.4 Canada Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Microbiome Therapeutics Export and Import (2013-2018)
10 Germany Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
10.1 Germany Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
10.2.1 Germany Microbiome Therapeutics Sales by Type (2013-2018)
10.2.2 Germany Microbiome Therapeutics Sales Market Share by Type (2013-2018)
10.3 Germany Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
10.3.1 Germany Microbiome Therapeutics Sales by Application (2013-2018)
10.3.2 Germany Microbiome Therapeutics Sales Market Share by Application (2013-2018)
10.4 Germany Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Microbiome Therapeutics Export and Import (2013-2018)
11 France Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
11.1 France Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
11.2 France Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
11.2.1 France Microbiome Therapeutics Sales by Type (2013-2018)
11.2.2 France Microbiome Therapeutics Sales Market Share by Type (2013-2018)
11.3 France "&Sheet1!$B$1&" Sales by Application (2013-2018)"
11.3.1 France Microbiome Therapeutics Sales by Application (2013-2018)
11.3.2 France Microbiome Therapeutics Sales Market Share by Application (2013-2018)
11.4 France Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Microbiome Therapeutics Revenue and Market Share by Manufacturer
11.5 France Microbiome Therapeutics Export and Import (2013-2018)
12 Italy Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
12.1 Italy Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
12.2.1 Italy Microbiome Therapeutics Sales by Type (2013-2018)
12.2.2 Italy Microbiome Therapeutics Sales Market Share by Type (2013-2018)
12.3 Italy Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
12.3.1 Italy Microbiome Therapeutics Sales by Application (2013-2018)
12.3.2 Italy Microbiome Therapeutics Sales Market Share by Application (2013-2018)
12.4 Italy Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Microbiome Therapeutics Export and Import (2013-2018)
13 Spain Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
13.1 Spain Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
13.2.1 Spain Microbiome Therapeutics Sales by Type (2013-2018)
13.2.2 Spain Microbiome Therapeutics Sales Market Share by Type (2013-2018)
13.3 Spain Microbiome Therapeutics Sales by Application (2013-2018)
13.3.1 Spain Microbiome Therapeutics Sales by Application (2013-2018)
13.3.2 Spain Microbiome Therapeutics Sales Market Share by Application (2013-2018)
13.4 Spain Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Microbiome Therapeutics Export and Import (2013-2018)
14 Microbiome Therapeutics Market Forecast (2018-2023)
14.1 North America and Europe Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
14.2 Microbiome Therapeutics Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.3 Microbiome Therapeutics Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Microbiome Therapeutics Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
14.4 Microbiome Therapeutics Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Microbiome Therapeutics Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
15 Microbiome Therapeutics Manufacturing Cost Analysis
15.1 Microbiome Therapeutics Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Microbiome Therapeutics
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Microbiome Therapeutics Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2017
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Data Source
Inquiry For Buying
North America and Europe Microbiome Therapeutics
Please fill out the form. We will contact you within 24 hours:
All fields required...
Request Sample
North America and Europe Microbiome Therapeutics
Please fill out the form. We will contact you within 24 hours:
All fields required...
